BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its contract researchers, Eno Research and Development, Inc. (ERDI), recently completed their analysis of a series of microarray studies with ReceptoPharm’s antiviral drug candidates in healthy immune cells.
